miRNAs for the diagnosis of nasopharyngeal carcinoma
An ebv-mir-bart8 and reagent technology, which can be used in the determination/inspection of microorganisms, medical preparations containing active ingredients, pharmaceutical formulations, etc., and can solve problems such as failure of nasopharyngeal cancer treatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0015] The technical solution of the present invention will be further described below in combination with experiments.
[0016] 1. miRNA microarray showed that EBV-miR-BART8 was upregulated in nasopharyngeal carcinoma
[0017] The inventors used NIH's in-house high-throughput miRNA chip to analyze nasopharyngeal carcinoma specimens (the specimens with nasopharyngeal carcinoma cell content accounting for more than 80% of the whole tissue after being processed by the general segmentation method) and non-cancerous nasopharyngeal epithelial tissues ( Chronic nasopharyngitis) specimens were analyzed for miRNA differential expression profiles, including 16 cases of nasopharyngeal carcinoma tissues and 20 cases of normal nasopharyngeal tissues. The specific steps and statistical methods for the extraction of total tissue RNA and miRNA microarray analysis are detailed in Reference 1. If the experiment is as shown in Table 1:
[0018] Table 1. Differentially expressed EBV miRNAs in m...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


